Increased extracellular dopamine concentrations and FosB/ΔFosB expression in striatal brain areas of heterozygous GDNF knockout mice
- 4 October 2004
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 20 (9) , 2336-2344
- https://doi.org/10.1111/j.1460-9568.2004.03700.x
Abstract
Glial cell line-derived neurotrophic factor (GDNF) has been shown to be involved in the maintenance of striatal dopaminergic neurons. To study whether reduced levels of endogenous GDNF affect the striatal dopaminergic transmission we estimated the basal extracellular levels of dopamine in vivo, the basal expression of FosB-related proteins in striatal brain areas as well as the effects of acute and repeated cocaine on locomotor activity and dopamine output in mice lacking one GDNF allele (heterozygous GDNF+/- mice). As expected the striatal GDNF protein content was found to be smaller in the GDNF+/- mice than in their wild-type littermates. Unexpectedly the extracellular dopamine concentration in the GDNF+/- mice in the dorsal striatum (CPu) was 2.0-fold, and in the nucleus accumbens (NAc) 1.6-fold the concentration found in the wild-type littermates. Also FosB/DeltaFosB-like immunoreactivity was found to be elevated in the CPu as well as in the core and in the shell of NAc of the GDNF+/- mice as compared with the wild-type mice. This suggests chronic postsynaptic activation of these brain areas and is in line with elevated extracellular dopamine concentrations. Cocaine's effects acutely and after repeated treatment on locomotor activity were similar in the GDNF+/- and the wild-type mice. Neither did cocaine's acute effects on dopamine output differ between the mice of the two strains. Our findings demonstrate that reduced levels of endogenous GDNF induce alterations in dorsal striatal and accumbal dopaminergic transmission, and stress the importance of endogenous GDNF in the regulation of the dopaminergic neurons.Keywords
This publication has 34 references indexed in Scilit:
- Time course of striatal ΔFosB‐like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatmentEuropean Journal of Neuroscience, 2003
- The GDNF family: Signalling, biological functions and therapeutic valueNature Reviews Neuroscience, 2002
- Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutationEuropean Journal of Neuroscience, 2001
- GDNF enhances the synaptic efficacy of dopaminergic neurons in cultureEuropean Journal of Neuroscience, 2000
- Differential effects of GDNF and BDNF on cultured ventral mesencephalic neuronsMolecular Brain Research, 1999
- Chronic Fos-Related Antigens: Stable Variants of ΔFosB Induced in Brain by Chronic TreatmentsJournal of Neuroscience, 1997
- GDNF Induces a Dystonia-like State in Neonatal Rats and Stimulates Dopamine and Serotonin SynthesisNeuron, 1996
- Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brainNature, 1995
- Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatumJournal of Neurophysiology, 1992
- Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion sizeJournal of Neuroscience, 1990